Sentiment Trading

Cigna Group’s stock price declined following President Trump’s executive order targeting ‘drug middlemen’ to reduce drug prices, but analysts remain optimistic about the company’s long-term prospects.

Cigna Group’s stock declined due to President Trump’s executive order on drug pricing and proposed Medicaid changes, but analysts remain optimistic about the company’s long-term prospects.